STOCK TITAN

[8-K] East-West Bancorp Inc Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Codexis, Inc. (CDXS) Form 4: 10% owner Opaleye Management Inc. reported an open-market purchase of 100,000 common shares on 07/18/2025 at $2.82 per share (≈ $282k). After the transaction, Opaleye now indirectly controls 12,450,000 shares through Opaleye L.P. and 250,000 shares through a separately managed account, totaling ≈ 12.7 million shares. No derivative positions were disclosed. Opaleye disclaims beneficial ownership beyond its pecuniary interest. As a Schedule 13D filer and 10% holder, continued accumulation can signal confidence and tighten the public float, although the added position represents <1 % of its existing stake.

Codexis, Inc. (CDXS) Modulo 4: Il detentore del 10%, Opaleye Management Inc., ha segnalato un acquisto sul mercato aperto di 100.000 azioni ordinarie il 18/07/2025 al prezzo di $2,82 per azione (circa $282.000). Dopo la transazione, Opaleye controlla indirettamente 12.450.000 azioni tramite Opaleye L.P. e 250.000 azioni tramite un conto gestito separatamente, per un totale di circa 12,7 milioni di azioni. Non sono state dichiarate posizioni derivati. Opaleye nega la titolarità beneficiaria oltre al proprio interesse pecuniario. In qualità di presentatore del Schedule 13D e detentore del 10%, un accumulo continuo può indicare fiducia e ridurre il flottante pubblico, anche se la posizione aggiuntiva rappresenta meno del 1% della sua quota esistente.

Codexis, Inc. (CDXS) Formulario 4: El propietario del 10%, Opaleye Management Inc., reportó una compra en mercado abierto de 100,000 acciones comunes el 18/07/2025 a $2.82 por acción (≈ $282,000). Tras la transacción, Opaleye controla indirectamente 12,450,000 acciones a través de Opaleye L.P. y 250,000 acciones mediante una cuenta gestionada por separado, sumando un total de aproximadamente 12.7 millones de acciones. No se divulgaron posiciones derivadas. Opaleye renuncia a la propiedad beneficiosa más allá de su interés pecuniario. Como presentador del Schedule 13D y poseedor del 10%, una acumulación continua puede indicar confianza y reducir el float público, aunque la posición añadida representa menos del 1% de su participación actual.

Codexis, Inc. (CDXS) 양식 4: 10% 지분 보유자인 Opaleye Management Inc.가 2025년 7월 18일에 주당 $2.82에 100,000주 보통주를 장내 매수했다고 보고했습니다(약 $282,000). 거래 후 Opaleye는 Opaleye L.P.를 통해 간접적으로 12,450,000주, 별도로 관리되는 계정을 통해 250,000주를 보유하여 총 약 1,270만주를 보유하게 되었습니다. 파생상품 포지션은 공개되지 않았습니다. Opaleye는 금전적 이익을 넘어선 실질 소유권을 부인합니다. Schedule 13D 제출자이자 10% 보유자로서 지속적인 매수는 신뢰를 나타내고 공개 유통 주식을 줄일 수 있으나, 추가된 포지션은 기존 지분의 1% 미만에 해당합니다.

Codexis, Inc. (CDXS) Formulaire 4 : Le détenteur de 10%, Opaleye Management Inc., a déclaré un achat sur le marché libre de 100 000 actions ordinaires le 18/07/2025 au prix de 2,82 $ par action (environ 282 000 $). Après la transaction, Opaleye contrôle indirectement 12 450 000 actions via Opaleye L.P. et 250 000 actions via un compte géré séparément, totalisant environ 12,7 millions d’actions. Aucune position dérivée n’a été divulguée. Opaleye décline toute propriété bénéficiaire au-delà de son intérêt pécuniaire. En tant que déposant du Schedule 13D et détenteur de 10%, une accumulation continue peut indiquer une confiance accrue et réduire le flottant public, bien que la position ajoutée représente moins de 1 % de sa participation actuelle.

Codexis, Inc. (CDXS) Formular 4: Der 10%-Eigentümer Opaleye Management Inc. meldete am 18.07.2025 einen Offenmarkt-Kauf von 100.000 Stammaktien zu je $2,82 (ca. $282.000). Nach der Transaktion kontrolliert Opaleye nun indirekt 12.450.000 Aktien über Opaleye L.P. und 250.000 Aktien über ein separat verwaltetes Konto, insgesamt etwa 12,7 Millionen Aktien. Es wurden keine Derivatpositionen offengelegt. Opaleye bestreitet eine wirtschaftliche Eigentümerschaft über sein finanzielles Interesse hinaus. Als Schedule 13D-Melder und 10%-Inhaber kann eine fortgesetzte Akkumulation Vertrauen signalisieren und den Streubesitz verringern, obwohl die hinzugefügte Position weniger als 1% seines bestehenden Anteils ausmacht.

Positive
  • Insider accumulation: A 10% owner added 100,000 shares in the open market, often viewed as a vote of confidence.
  • Stake increase: Total indirect holdings rise to ≈ 12.7 million shares, tightening float and aligning insider with shareholder value.
Negative
  • Scale of purchase is small: The 100k-share buy raises the position by less than 1 %, so informational impact may be limited.

Insights

TL;DR: 10% owner bought 100k CDXS shares at $2.82, nudging stake to 12.7 M; small addition but positive insider signal.

Opaleye’s purchase increases its indirect ownership by roughly 0.8 %, bringing its total to about 12.7 million shares. While the dollar value is modest relative to its holding, insider buying—especially by a large shareholder—tends to be interpreted favorably because the investor is committing fresh capital at prevailing market prices. No dispositions or derivative exercises were reported, indicating a straightforward cash purchase. The filing is impactful mainly as a sentiment indicator; it does not alter Codexis’s fundamentals or capital structure but may support near-term share demand and investor confidence.

Codexis, Inc. (CDXS) Modulo 4: Il detentore del 10%, Opaleye Management Inc., ha segnalato un acquisto sul mercato aperto di 100.000 azioni ordinarie il 18/07/2025 al prezzo di $2,82 per azione (circa $282.000). Dopo la transazione, Opaleye controlla indirettamente 12.450.000 azioni tramite Opaleye L.P. e 250.000 azioni tramite un conto gestito separatamente, per un totale di circa 12,7 milioni di azioni. Non sono state dichiarate posizioni derivati. Opaleye nega la titolarità beneficiaria oltre al proprio interesse pecuniario. In qualità di presentatore del Schedule 13D e detentore del 10%, un accumulo continuo può indicare fiducia e ridurre il flottante pubblico, anche se la posizione aggiuntiva rappresenta meno del 1% della sua quota esistente.

Codexis, Inc. (CDXS) Formulario 4: El propietario del 10%, Opaleye Management Inc., reportó una compra en mercado abierto de 100,000 acciones comunes el 18/07/2025 a $2.82 por acción (≈ $282,000). Tras la transacción, Opaleye controla indirectamente 12,450,000 acciones a través de Opaleye L.P. y 250,000 acciones mediante una cuenta gestionada por separado, sumando un total de aproximadamente 12.7 millones de acciones. No se divulgaron posiciones derivadas. Opaleye renuncia a la propiedad beneficiosa más allá de su interés pecuniario. Como presentador del Schedule 13D y poseedor del 10%, una acumulación continua puede indicar confianza y reducir el float público, aunque la posición añadida representa menos del 1% de su participación actual.

Codexis, Inc. (CDXS) 양식 4: 10% 지분 보유자인 Opaleye Management Inc.가 2025년 7월 18일에 주당 $2.82에 100,000주 보통주를 장내 매수했다고 보고했습니다(약 $282,000). 거래 후 Opaleye는 Opaleye L.P.를 통해 간접적으로 12,450,000주, 별도로 관리되는 계정을 통해 250,000주를 보유하여 총 약 1,270만주를 보유하게 되었습니다. 파생상품 포지션은 공개되지 않았습니다. Opaleye는 금전적 이익을 넘어선 실질 소유권을 부인합니다. Schedule 13D 제출자이자 10% 보유자로서 지속적인 매수는 신뢰를 나타내고 공개 유통 주식을 줄일 수 있으나, 추가된 포지션은 기존 지분의 1% 미만에 해당합니다.

Codexis, Inc. (CDXS) Formulaire 4 : Le détenteur de 10%, Opaleye Management Inc., a déclaré un achat sur le marché libre de 100 000 actions ordinaires le 18/07/2025 au prix de 2,82 $ par action (environ 282 000 $). Après la transaction, Opaleye contrôle indirectement 12 450 000 actions via Opaleye L.P. et 250 000 actions via un compte géré séparément, totalisant environ 12,7 millions d’actions. Aucune position dérivée n’a été divulguée. Opaleye décline toute propriété bénéficiaire au-delà de son intérêt pécuniaire. En tant que déposant du Schedule 13D et détenteur de 10%, une accumulation continue peut indiquer une confiance accrue et réduire le flottant public, bien que la position ajoutée représente moins de 1 % de sa participation actuelle.

Codexis, Inc. (CDXS) Formular 4: Der 10%-Eigentümer Opaleye Management Inc. meldete am 18.07.2025 einen Offenmarkt-Kauf von 100.000 Stammaktien zu je $2,82 (ca. $282.000). Nach der Transaktion kontrolliert Opaleye nun indirekt 12.450.000 Aktien über Opaleye L.P. und 250.000 Aktien über ein separat verwaltetes Konto, insgesamt etwa 12,7 Millionen Aktien. Es wurden keine Derivatpositionen offengelegt. Opaleye bestreitet eine wirtschaftliche Eigentümerschaft über sein finanzielles Interesse hinaus. Als Schedule 13D-Melder und 10%-Inhaber kann eine fortgesetzte Akkumulation Vertrauen signalisieren und den Streubesitz verringern, obwohl die hinzugefügte Position weniger als 1% seines bestehenden Anteils ausmacht.

0001069157false00010691572025-07-222025-07-22


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K


CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)
July 22, 2025

EAST WEST BANCORP, INC.
(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of incorporation)

000-24939
(Commission File Number)

95-4703316
(IRS Employer Identification No.)

135 North Los Robles Ave., 7th Floor, Pasadena, California 91101
(Address of principal executive offices) (Zip code)

(626) 768-6000
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: 
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.001 per shareEWBCThe Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 2.02. Results of Operations and Financial Condition

On July 22, 2025, East West Bancorp, Inc. (the “Company”) announced its financial results for the quarter ended June 30, 2025. A copy of the Company’s press release (the “Press Release”) is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference in this Item 2.02. The Press Release is “furnished” pursuant to General Instruction B.2 of Form 8-K and the information provided in Item 2.02 of this report, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of such Section. The information provided in Item 2.02 of this report, including Exhibit 99.1, shall not be deemed incorporated by reference into any filings the Company has made or may make under the Securities Act of 1933 (the “Securities Act”) or the Exchange Act, except as otherwise expressly stated in such filing.

Item 7.01. Regulation FD Disclosure

On July 22, 2025, the Company will hold a conference call to discuss its financial results for the quarter ended June 30, 2025 and other matters relating to the Company. The Company has also made available on its website, www.eastwestbank.com, presentation materials containing certain historical and forward-looking information relating to the Company (the “Presentation Materials”). The Presentation Materials are furnished as Exhibit 99.2 and are incorporated by reference in this Item 7.01. All information in Exhibit 99.2 is presented as of the particular date or dates referenced therein, and the Company does not undertake any obligation to, and disclaims any duty to, update any of the information provided. The information provided in Item 7.01 of this report, including Exhibit 99.2, shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of such Section, nor shall such information be deemed incorporated by reference into any filings the Company has made or may make under the Securities Act or the Exchange Act, except as otherwise expressly stated in such filing.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits
99.1
Press Release, dated July 22, 2025.
99.2
Presentation Materials, dated July 22, 2025.
104Cover Page Interactive Data (formatted in Inline XBRL).



2



SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 EAST WEST BANCORP, INC.
  
Date: July 22, 2025By:/s/ Christopher J. Del Moral-Niles 
Christopher J. Del Moral-Niles
  Executive Vice President and Chief Financial Officer



3

FAQ

How many Codexis (CDXS) shares did Opaleye buy?

The Form 4 shows an open-market purchase of 100,000 shares.

What price did the insider pay for CDXS shares?

Opaleye bought the shares at $2.82 per share on 07/18/2025.

What is Opaleye’s total ownership in Codexis after the transaction?

Opaleye now indirectly controls 12,450,000 shares via its fund plus 250,000 shares in a managed account—≈ 12.7 million total.

Were any derivative securities involved in this Form 4 filing?

No. The filing lists no derivative acquisitions or dispositions.

Why is Opaleye listed as a 10% owner of Codexis?

Its aggregate holdings exceed 10 % of outstanding CDXS shares, triggering the Section 16 designation.
East West Bancorp Inc

NASDAQ:EWBC

EWBC Rankings

EWBC Latest News

EWBC Stock Data

14.89B
136.39M
1.06%
92.6%
2.39%
Banks - Regional
State Commercial Banks
Link
United States
PASADENA